Danny Sahtoe
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (5)
Protein aggregates are a pathological hallmark across neurodegenerative diseases. Yet, the disconnect between molecular-level aggregation and the emergence of disease severely limits mechanistic understanding of neurodegeneration. Here, we bridge this disconnect by showing that a cellular tipping point emerges as a universal feature across diseases from the competition between aggregate accumulation and removal. We map the resulting cellular phase transition with our high-throughput live-cell assay, measuring the tipping point that separates healthy cells from those with large aggregate loads. Using super-resolution imaging of brain tissue from Alzheimer’s and Parkinson’s disease, we quantify how the balance of accumulation and removal is shifted in disease. We validate our framework by predicting how designed aggregation inhibitors shift the tipping point to restore cellular homeostasis. Our results provide a mechanistic framework connecting molecular-level aggregation to disease, paving the way for a quantitative, unified understanding of neurodegeneration and enabling predictions of therapeutic efficacy.
Year:
2025
Protein design has focused primarily on the design of ground states, ensuring they are sufficiently low energy to be highly populated. Designing the kinetics and dynamics of a system requires, in addition, the design of excited states that are traversed in transitions from one low-lying state to another. This is a challenging task as such states must be sufficiently strained to be poorly populated, but not so strained that they are not populated at all, and because protein design methods have generally focused on creating near-ideal structures. Here we describe a general approach for designing systems which use an induced-fit power stroke to generate a structurally frustrated and strained excited state, allosterically driving protein complex dissociation. X-ray crystallography, double electron-electron resonance spectroscopy, and kinetic binding measurements demonstrate that incorporating excited states enables design of effector-induced increases in dissociation rates as high as 6000-fold. We highlight the power of this approach by designing cytokine mimics which can be dissociated within seconds from their receptors.
Year:
2024
Year:
2022
Year:
2021
Year:
2021
Collaborators (13)
Tuomas Knowles
1920 Professor of Physical Chemistry
University of Cambridge
Shriram Venkatesan
Research Specialist
Stowers Institute for Medical Research
David Baker
Professor
University of Washington
Stefan Stoll
Professor
University of Washington
William A. McEwan
University of Cambridge
Daniel Zuckerman
Professor
Oregon Health & Science University
Mohamad Abedi
Assistant Professor
University of California, Los Angeles
Georg Meisl
Assistant Research Professor
University of Cambridge
David Klenerman
University of Cambridge
Alain Goriely
University of Oxford
Randal Halfmann
Associate Investigator
Stowers Institute for Medical Research
Joseph Beckwith
Assistant Professor
University of Warwick
Jacob Piehler
Professor of Biophysics
University of Osnabrück
Make your next move.
Prepare your application
Review drafts before you send them.